Inklings program for infants: Caregiver experiences and mental health
Friday, June 13, 2025 |
3:10 PM - 3:20 PM |
Overview
Details
⏲️ 3.10pm - 3.30pm
⌛ 20-minutes
📚 Assumed knowledge of attendees: Foundational (new/casual familiarity with the topic e.g. treated a single case)
Presenter
Inklings program for infants: Caregiver experiences and mental health
3:10 PM - 3:30 PMPresentation summary
Caregiver-mediated supports are increasingly emerging as an evidence-based approach to supporting children’s development, especially in the earliest years of life. Outcomes from trials of caregiver-mediated supports have predominantly focused on child-related developmental outcomes and/or caregiver-child interaction changes (i.e., outcomes proximal to the therapy target). The impact of caregiver-mediated supports on caregiver mental health is rarely explored, despite evidence that caregivers of neurodivergent children experience increased rates of mental health challenges.
Methods:
We conducted a secondary analysis of data from an Australian randomised clinical trial (RCT) of the Inklings program (also referred to as iBASIS-VIPP). This analysis describes the mental health of caregivers participating in the program at baseline and immediately post-therapy and compares changes in levels of depression, anxiety and stress (DASS-21) between groups over the therapy period. The secondary analysis also explores how depression, anxiety and stress symptoms are related to core domains targeted by the program, including caregiver non-directiveness and sensitive responding. Clinical reflections from practitioners and trainers within the Inklings Community of Practice supports interpretation of the analysis relating to parental mental wellbeing.
Results:
Secondary analysis found mean DASS-21 scores in the sample at baseline and treatment-endpoint are consistent with population-level samples. There were no differences in DASS-21 scores at baseline between treatment groups. The Inklings/iBASIS-VIPP caregiver mediated support did not increase caregiver DASS-21 scores on any subdomain from baseline to treatment-endpoint. Caregivers assigned to care as usual showed increasing rates of anxiety over the therapy period.
Conclusions:
This presentation will share new findings from a secondary analysis of RCT data of the Inklings/iBASIS-VIPP program, and discuss these with consideration of clinical reflection of the experiences caregivers within the program within the community implementation of the program in Western Australia.
Refrences
Whitehouse AJO, Varcin KJ, Alvares GA, et al. (2019). Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: a single-blind, randomised controlled trial. The Lancet Child & Adolescent Health, 3(9), 605-615.
Whitehouse AJO, Varcin KJ, Pillar S, et al. (2021). Effect of preemptive intervention on developmental outcomes among infants showing early signs of autism: a randomized clinical trial of outcomes to diagnosis. JAMA Pediatrics, 175(11), e213290.
**********
The information contained in this program is current at of the time of publishing but is subject to changes made without notice.
Disclaimer: © (2024) The Speech Pathology Association of Australia Limited. All rights reserved.
Important Notice, please read: The views expressed in this presentation and reproduced in these materials are not necessarily the views of, or endorsed by, The Speech Pathology Association of Australia Limited ("the Association"). The Association makes no warranty or representation in relation to the content, currency or accuracy of any of the materials comprised in this presentation. The Association expressly disclaims any and all liability (including liability for negligence) in respect of use of these materials and the information contained within them. The Association recommends you seek independent professional advice prior to making any decision involving matters outlined in this presentation including in any of the materials referred to or otherwise incorporated into this presentation.
.
